PDGF-BB Murine Recombinant Protein for Cell Assays
2026-08-29
PDGF-BB is a recombinant homodimeric growth factor used to stimulate receptor-dependent cell proliferation. Murine recombinant PDGF-BB provides defined structural, purity, endotoxin, reconstitution, and activity specifications for controlled in-vitro assays, including smooth muscle cell proliferation studies.
Cell lysis buffer for WB and IP: Lab Guide
2026-08-29
Learn how Cell lysis buffer for WB and IP (SKU K1123) supports reproducible protein extraction for Western blotting, immunoprecipitation, and signaling studies. This scenario-based guide connects inhibitor selection and non-denaturing lysis to investigations of cancer-associated fibroblasts, mitochondrial metabolism, and chemoresistance.
Bi-Layer Tranexamic Acid Dressings for Trauma Hemostasis
2026-08-28
This 2024 study presents a bi-layer wound dressing that combines Tranexamic Acid, nitric oxide release, and propolis to address rapid hemorrhage control and bacterial contamination in trauma. Early platelet-associated clot formation, dense fibrin architecture, and substantial reductions in bacterial colony counts support the design as a promising research platform, although further in vivo and translational validation is needed.
From Fluorescent RNA to In Situ TIL Translation
2026-08-28
Cy5-UTP turns RNA probe synthesis into a strategic assay for tracking delivery, localization, and expression in translational immunology. By connecting Cyanine 5-uridine triphosphate with the in situ TIL therapy framework reported in ACS Nano, this article shows how fluorescent RNA labeling can strengthen preclinical decision-making while clarifying the boundaries between an analytical surrogate and a therapeutic mRNA.
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-08-27
The reference study identifies the WNT5a/GSK3/β-catenin axis as a central regulator of adipogenic differentiation in skeletal-muscle fibro/adipogenic progenitors. By combining pharmacological perturbation, high-dimensional cytometry, transcriptomic integration, network modeling, and mouse injury models, it connects suppression of GSK3 with reduced fatty degeneration and improved muscle-supportive FAP activity.
Necrostatin-1: A Translational RIP1 Strategy
2026-08-27
A thought-leadership framework for using Necrostatin-1 as a causal probe of RIP1 kinase signaling, linking necroptosis assays with inflammatory lung disease, tissue injury, and acute kidney injury research.
FPS-ZM1: Translating RAGE Biology from Metabolism to AD
2026-08-26
A translational framework for using FPS-ZM1 to test how RAGE links hypothalamic metabolic stress, amyloid beta signaling, blood-brain barrier transport, and neuroinflammation—while keeping preclinical evidence and clinical expectations distinct.
AP20187: Turning Dimerization into Translation
2026-08-26
AP20187 is a chemical inducer of dimerization that converts engineered protein proximity into controllable signaling. This thought-leadership guide connects its mechanism and validation profile with translational design lessons from chronic intermittent hypoxia research.
Phosphatase Inhibitor Cocktail: Preserve Signal
2026-08-25
Learn how the Phosphatase Inhibitor Cocktail (2 Tubes, 100X) supports protein phosphorylation preservation across lysate workflows. This article adds a decision framework linking phosphatase control to the APEX2–TERT study and orthogonal assay interpretation.
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO)
2026-08-25
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) helps limit endogenous proteolysis during cell and tissue protein extraction, including workflows prepared for mass spectrometry. It is not a complete substitute for metalloproteinase or phosphatase control; add and validate EDTA or dedicated inhibitors separately when those activities are relevant.
Antipyrine in BBB Permeability Research
2026-08-24
Antipyrine combines high water compatibility with a well-defined analytical profile, making it a practical comparator for BBB transport, pharmacokinetic studies, and drug metabolism research. This guide shows how to integrate it into LLC-PK1-MOCK/MDR1 assays while separating passive permeability from efflux and lysosomal-trapping artifacts.
GRA12 Revealed by In Vivo CRISPR Screening
2026-08-23
A pooled in vivo CRISPR-Cas9 study identifies the dense-granule protein GRA12 as a conserved Toxoplasma gondii virulence factor across parasite strains and mouse backgrounds. Functional validation links GRA12 to parasitophorous-vacuole stability and protection from immune-associated host-cell necrosis, establishing a framework for studying broadly conserved host–parasite mechanisms.
BKT140: A CXCR4 Assay Decision Framework
2026-08-22
BKT140 and BL-8040 provide a functional way to interrogate CXCR4 signaling across cancer migration, apoptosis, and stem cell mobilization. This article translates recent CXCR4 theranostic findings into endpoint-specific assay design and interpretation strategies.
Prednisone Workflows for PBL Apoptosis Research
2026-08-21
Prednisone provides a practical way to model G1-phase arrest, IL-2 pathway suppression, and lymphocyte apoptosis in controlled cell-based experiments. This guide connects PBL assays with chemical-stability checks, neurodegeneration models, and troubleshooting strategies for more reproducible results.
Machine-Learning Discovery of Senolytics
2026-08-20
The reference study presents a cost-efficient machine-learning workflow that uses published screening data to identify senolytic candidates without requiring a large new proprietary dataset. Computational screening followed by testing in human cell models identified ginkgetin, periplocin, and oleandrin as active compounds, while also illustrating how heterogeneous literature data can accelerate early-stage drug discovery.
461 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page